Breast Cancer Research and Treatment

, Volume 10, Issue 1, pp 5–9

Prognostic factors for recurrence and survival in human breast cancer

  • Wiliam L. McGuire
9th San Antonio Breast Cancer Symposium: Plenary lecture

Summary

Since only about half of primary breast cancer patients are cured by local treatment, factors which can predict which patients are likely to recur and should thus receive preventive treatmrnt are needed. Here, work on such prognostic factors which has been going on in San Antonio for many years will be reviewed. The significance of the number of involved axillary nodes and of steroid receptors is already well known, while the value of tumor proliferative rate and ploidy has been appreciated more recently, and the significance of amplification of the oncogene HER-2/neu is just now emerging.

Key words

aneuploidy estrogen receptor flow cytometry HER-2/neu nodal status oncogene progesterone receptor prognosis proliferative rate S-phase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Knight, WA III, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671, 1977Google Scholar
  2. 2.
    Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS: Progesterone receptor as a prognostic factor in Stage II breast cancer. N Engl J Med 309: 1343–1347, 1983PubMedGoogle Scholar
  3. 3.
    Meyer JS: Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma. NCI Monogr 1: 25–28, 1986PubMedGoogle Scholar
  4. 4.
    Silvestrini R, Daidone MG, DiFronzo G, Morabito A, Valagussa P, Bonadonna G: Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat 7: 161–169, 1986PubMedGoogle Scholar
  5. 5.
    Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP: The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer 33: 441–445, 1984PubMedGoogle Scholar
  6. 6.
    McGuire WL, Meyer JS, Barlogie B, Kute TE: Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat 5: 117–128, 1985PubMedGoogle Scholar
  7. 7.
    McGuire WL, Dressler LG: The emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst 75: 405–410, 1985PubMedGoogle Scholar
  8. 8.
    Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Amplification of the HER-2/neu oncogene correlates with relapse and survival in human breast cancer. Science 235: 177–182, 1987PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers 1987

Authors and Affiliations

  • Wiliam L. McGuire
    • 1
  1. 1.Medicine/OncologyUniversity of Texas Health Science CenterSan AntonioUSA

Personalised recommendations